Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
- 3rd side (hint)
amantadine MOA
|
"a man to dine" take off his coat. Blocks viral penetration/ uncoating (M2 prot); may buffer pH of endosome. Release of dopamine from intact nerve terminals.
|
|
|
amantadine clinical use
|
Manatadine blocks influenza A and rubellA and causes problemms with the cerebellA. Tx for parkinsons
|
|
|
amantadine toxicity
|
ataxia, dizzyness, slurred speech
|
|
|
amantadine mechanism of resistance
|
mutated M2 prot. 90% flu resistant to amantadine. Rimantadine has less AE's and doesn’t X BBB
|
|
|
zanamivir, oseltamivir MOA
|
inhibits influenza neuraminidase. Progeny release decreased
|
|
|
zanamivir, oseltamivir clinical use
|
influenza A, B
|
|
|
ribavirin MOA
|
inhibits syn of guanine nucleotides by competitively inhibiting IMP dehydrogenase
|
|
|
ribavirin clinical use
|
RSV, chronic hep C
|
|
|
ribavirin toxicity
|
hemolytic anemia. Severe teratogen
|
|
|
acyclovir MOA
|
inhibits viral DNA pol when PHOSPHORYLATED BY VIRAL THYMIDINE KINASE
|
|
|
acyclovir clinical use
|
HSV, VZV, EBV. Mucocutaneous and genital herpes lesions. Prophylax in immunocompromised patients
|
|
|
acyclovir toxicity
|
delerium, tremor, nephrotoxicity
|
|
|
acyclovir mech of resistance
|
lack of thymidine kinase
|
|
|
gancyclovir MOA
|
phosphorylation by viral kinase. Pref inhibits CMV DNA polymerase
|
|
|
gancyclovir clinical use
|
CMV, esp in immunocompromised pts.
|
|
|
gancyclovir toxicity
|
leukopenia, neutropenia, thrombocytopenia, renal tox. More toxic to host enzymes than acyclovir
|
None
|
|
gancyclovir mech of resistance
|
mutated CMV DNA polymerase or lack of thymidine kinase
|
|
|
foscarnet MOA
|
viral DNA pol inhibitor tha tbinds pyrophosphate binding site of the enz. DOES NOT REQUIRE ACTIVATION BY VIRAL KINASE
|
|
|
foscarnet flinical use
|
CMV retinitis in immuno comporomised when gancyclovir fails. Acyclovir resistant HSV
|
|
|
foscarnet tox
|
nephrotoxicity
|
|
|
foscarnet mechanism of resistance
|
mutated DNA polymerase
|
|